https://www.ft.com/content/7220cbdd-4b8c-49f1-9cf7-5146a691adb6 The World Health Organization is set to add Sinopharm’s vaccine to its list of approved Covid-19 jabs, people familiar with the matter said, in a boost for the Chinese-made shot amid doubts over its efficacy. The emergency use listing is for a two-shot regimen for all adults aged 18 and over, the people said. It is the first vaccine of any kind made in China to receive emergency use authorisation from the WHO. The approval acts as a signal to countries around the world that the Sinopharm vaccine is safe to use and allows for the shot to be added to the WHO’s vaccine procurement programme Covax. The announcement could be made as early as Friday afternoon, the people said. Early stage studies for the shot were mainly conducted in China, where coronavirus has already been contained. Final stage, or phase 3, studies were mostly conducted overseas. The approval is a win for Sinopharm, which is the dominant producer of vaccines for China’s domestic market and supplies the majority of jabs for state-run immunisation programmes but has yet to establish itself as an exporter of vaccines. The company did not immediately respond to a request for comment. China has pledged Covid vaccines across the developing world but the international rollout has been hampered by lingering concerns about the shot’s efficacy, as Chinese manufacturers have been slower than western candidates to release detailed trial data.
https://www.ft.com/content/7220cbdd-4b8c-49f1-9cf7-5146a691adb6 The World Health Organization is set to add Sinopharm’s vaccine to its list of approved Covid-19 jabs, people familiar with the matter said, in a boost for the Chinese-made shot amid doubts over its efficacy. The emergency use listing is for a two-shot regimen for all adults aged 18 and over, the people said. It is the first vaccine of any kind made in China to receive emergency use authorisation from the WHO. The approval acts as a signal to countries around the world that the Sinopharm vaccine is safe to use and allows for the shot to be added to the WHO’s vaccine procurement programme Covax. The announcement could be made as early as Friday afternoon, the people said. Early stage studies for the shot were mainly conducted in China, where coronavirus has already been contained. Final stage, or phase 3, studies were mostly conducted overseas. The approval is a win for Sinopharm, which is the dominant producer of vaccines for China’s domestic market and supplies the majority of jabs for state-run immunisation programmes but has yet to establish itself as an exporter of vaccines. The company did not immediately respond to a request for comment. China has pledged Covid vaccines across the developing world but the international rollout has been hampered by lingering concerns about the shot’s efficacy, as Chinese manufacturers have been slower than western candidates to release detailed trial data. bigjohn123456 发表于 2021-05-07 12:00
https://www.ft.com/content/7220cbdd-4b8c-49f1-9cf7-5146a691adb6
The World Health Organization is set to add Sinopharm’s vaccine to its list of approved Covid-19 jabs, people familiar with the matter said, in a boost for the Chinese-made shot amid doubts over its efficacy.
The emergency use listing is for a two-shot regimen for all adults aged 18 and over, the people said. It is the first vaccine of any kind made in China to receive emergency use authorisation from the WHO.
The approval acts as a signal to countries around the world that the Sinopharm vaccine is safe to use and allows for the shot to be added to the WHO’s vaccine procurement programme Covax.
The announcement could be made as early as Friday afternoon, the people said. Early stage studies for the shot were mainly conducted in China, where coronavirus has already been contained. Final stage, or phase 3, studies were mostly conducted overseas.
The approval is a win for Sinopharm, which is the dominant producer of vaccines for China’s domestic market and supplies the majority of jabs for state-run immunisation programmes but has yet to establish itself as an exporter of vaccines. The company did not immediately respond to a request for comment.
China has pledged Covid vaccines across the developing world but the international rollout has been hampered by lingering concerns about the shot’s efficacy, as Chinese manufacturers have been slower than western candidates to release detailed trial data.
估计一大堆正飞速赶来断定WHO被中国收买。
你还给人说话的机会了不？
而且，本版有网友觉得辉瑞副作用大的，因此需要开放专利让全世界除了美国德国外的科学家帮助美国和德国发展更好疫苗的，可以不用这么麻烦，下一波直接打国产疫苗了。
大家都有办法打到自己想打的疫苗，真好。赞！
中国外交部发言人汪文斌：”新冠肺炎疫情发生以来，中方一直坚持疫苗“全球公共产品”的第一属性，以实际行动确保疫苗在发展中国家的可及性和可负担性，包括同发展中国家开展技术转让和合作生产等方面的合作。我们也将继续支持一切有利于发展中国家及时、公平获取疫苗的行动。“
科兴过几天肯定也会批，时间问题。现在疫情这么严重，有效率低一点总比裸奔强
大国气度，赞！但是遇到卢旺达这样的国家，个人看法，免费送也别合作生产，太可怕了。
说是下周会公布批准科兴与否。应该大概率批的，科兴的数据更好，没理由批国药不批科兴的
同问，怎么会反而先批国药呢？
不过科兴应该也快了吧。
国药打的人多？国内我认识的青壮中年期本都打了，好多六十多的老人也打了
哈哈哈哈哈哈
赞总结!
这个点评很到位
国药这么数据明显有问题的都能批准，科兴更加能批准。 来，以后咱们左胳膊一针，右胳膊一针的国药疫苗打起来。
是啊，还有好多国家没有疫苗，疫苗赶紧在全世界铺开疫情才能快点结束
我在网上看到国内真的有人第一针国药第二针科兴
问题是铺开没有效力的疫苗会起反作用 塞浦路斯 智利 巴西都是例子
对啊，为啥先批国药？
科兴的流程比国药慢一周左右
滚